nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancements in biosensors for cancer detection: revolutionizing diagnostics
|
Mustafa, Syed Khalid |
|
|
41 |
3 |
|
artikel |
2 |
A therapeutical insight into the correlation between circRNAs and signaling pathways involved in cancer pathogenesis
|
Saleh, Raed Obaid |
|
|
41 |
3 |
|
artikel |
3 |
C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation
|
Al Shahrani, Mesfer |
|
|
41 |
3 |
|
artikel |
4 |
Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target
|
Raja, David |
|
|
41 |
3 |
|
artikel |
5 |
Correction to: Exploring the advances of single‑cell RNA sequencing in thyroid cancer: a narrative review
|
Tan, Joecelyn Kirani |
|
|
41 |
3 |
|
artikel |
6 |
CRP inhibits the osteoblastic differentiation of OPCs via the up-regulation of primary cilia and repression of the Hedgehog signaling pathway
|
Xu, Jie |
|
|
41 |
3 |
|
artikel |
7 |
Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cells
|
Muduli, Kartik |
|
|
41 |
3 |
|
artikel |
8 |
Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)
|
Taylor, Alexander S. |
|
|
41 |
3 |
|
artikel |
9 |
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity
|
You, Qiang |
|
|
41 |
3 |
|
artikel |
10 |
Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds
|
Wu, Liyi |
|
|
41 |
3 |
|
artikel |
11 |
Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment
|
Akbari, Parinaz |
|
|
41 |
3 |
|
artikel |
12 |
Selective targeting or reprogramming of intra-tumoral Tregs
|
Mortezaee, Keywan |
|
|
41 |
3 |
|
artikel |
13 |
Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach
|
Arumugam, Gobika |
|
|
41 |
3 |
|
artikel |
14 |
The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study
|
Alalikhan, Abbas |
|
|
41 |
3 |
|
artikel |
15 |
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma
|
Yin, Yu-Ting |
|
|
41 |
3 |
|
artikel |
16 |
Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment
|
Haines, Nathan A. |
|
|
41 |
3 |
|
artikel |
17 |
Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1
|
Ha, Jackie L. |
|
|
41 |
3 |
|
artikel |
18 |
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
|
Bouligny, Ian M. |
|
|
41 |
3 |
|
artikel |